Common use of Defective Product Clause in Contracts

Defective Product. If Client rejects Products under Section 6.1 and the deviation is determined to have arisen from Patheon’s failure to provide the Manufacturing Services in accordance with the Specifications, cGMPs, or Applicable Laws, Patheon will credit Client’s account for Patheon’s invoice price for the defective Products. If Client previously paid for the defective Products, Patheon will promptly, at Client’s election, either: (i) refund the invoice price for the defective Products; (ii) offset the amount paid against other amounts due to Patheon hereunder; or (iii) replace the Products with conforming Products, (provided that Patheon is able to manufacture replacement Product at the same Manufacturing Site as that of the rejected Products), without Client being liable for payment therefor under Section 3.1, contingent upon the receipt from Client of all Active Materials and Client-Supplied Components required for the manufacture of the replacement Products. For greater certainty, Patheon’s responsibility for any loss of Active Materials in defective Product will be captured and calculated in the Active Materials Yield under Section 2.2.

Appears in 2 contracts

Samples: Product Agreement (Tetraphase Pharmaceuticals Inc), Product Agreement (La Jolla Pharmaceutical Co)

AutoNDA by SimpleDocs

Defective Product. If Client rejects Products under Section 6.1 and the deviation is determined to have arisen from Patheon’s failure to provide the Manufacturing Services in accordance with the Specifications, cGMPs, or Applicable Laws, or the other requirements of this Agreement or the applicable Product Agreement) Patheon will credit Client’s account for Patheon’s invoice price for the defective Products. If Client previously paid for the defective Products, Patheon will promptly, at Client’s election, either: (i) refund the invoice price for the defective Products; (ii) offset the amount paid against other amounts due to Patheon hereunder; or (iii) replace the Products with conforming Products, (provided that Patheon is able to manufacture replacement Product at the same Manufacturing Site as that of the rejected Products), Products without Client being liable for payment therefor therefore under Section 3.1, contingent upon the receipt from Client of all Active Materials and Client-Supplied Components required for the manufacture of the replacement Products. For greater certaintyclarity, Patheon’s responsibility for any loss of Active Materials in defective Product will be captured and calculated in the Active Materials Yield under Section 2.2. Patheon shall promptly reimburse Client for all costs related to the production and shipment of the Client-Supplied Components to Patheon related to the defective Product.

Appears in 2 contracts

Samples: Master Manufacturing Services Agreement (Akebia Therapeutics, Inc.), Product Agreement (Keryx Biopharmaceuticals Inc)

Defective Product. If Client rejects Products under Section 6.1 and the deviation is determined to have arisen from Patheon’s failure to provide the Manufacturing Services in accordance with the Specifications, cGMPs, or Applicable Laws, Patheon will credit Client’s account for Patheon’s invoice price for the defective Products. If Client previously paid for the defective Products, Patheon will promptly, at Client’s election, either: (i) refund the invoice price for the defective Products; (ii) offset the *** Confidential Treatment Requested Master Manufacturing Services Agreement amount paid against other amounts due to Patheon hereunder; or (iii) replace the Products with conforming Products, (provided that Patheon is able to manufacture replacement Product at the same Manufacturing Site as that of the rejected Products), Products without Client being liable for payment therefor under Section 3.1, contingent upon the receipt from Client of all Active Materials and Client-Supplied Components required for the manufacture of the replacement Products. For greater certainty, Patheon’s responsibility for any loss of Active Materials in defective Product will be captured and calculated in the Active Materials Yield under Section 2.2.

Appears in 1 contract

Samples: Product Agreement (Horizon Pharma, Inc.)

Defective Product. If Client rejects Products Product under Section 6.1 and the deviation Patheon agrees, or it is determined pursuant to have arisen Section 6.1(b), that the deficiency arose from Patheon’s failure to provide the Manufacturing Services in accordance with the Specifications, cGMPs, cGMPs or Applicable Laws, Patheon will credit Client’s account for Patheon’s invoice price for the defective ProductsProduct. If Client previously paid for the defective ProductsProduct, Patheon will promptly, at Client’s election, either: (i) refund the invoice price for the defective ProductsProduct; (ii) offset the amount paid against other amounts due to Patheon hereunder; or (iii) replace the Products Product with conforming Products, Product (provided that if Patheon is able to manufacture the replacement Product at the same Manufacturing Site as that of the rejected ProductsProduct), without Client being liable for payment therefor under Section 3.1, contingent upon the receipt from Client of all Active Materials Material and Client-Supplied Components required for the manufacture of the replacement ProductsProduct. For greater certainty, Patheon’s responsibility for any loss of Active Materials Material in defective Product will be captured and calculated in the Active Materials Material Yield under Section 2.2.

Appears in 1 contract

Samples: Manufacturing Services Agreement (Nabriva Therapeutics PLC)

AutoNDA by SimpleDocs

Defective Product. If Client rejects Products under Section 6.1 and the deviation is determined to have arisen from Patheon’s failure to provide the Manufacturing Services in accordance with the Specifications, cGMPs, or Applicable Laws, Patheon will credit Client’s account for Patheon’s invoice price for the defective Products. If Client previously paid for the defective Products, Patheon will promptly, at Client’s election, either: (i) refund the invoice price for the defective Products; (ii) offset the ***Confidential Treatment Requested Master Manufacturing Services Agreement amount paid against other amounts due to Patheon hereunder; or (iii) replace the Products with conforming Products, (provided that Patheon is able to manufacture replacement Product at the same Manufacturing Site as that of the rejected Products), Products without Client being liable for payment therefor under Section 3.1, contingent upon the receipt from Client of all Active Materials and Client-Supplied Components required for the manufacture of the replacement Products. For greater certainty, Patheon’s responsibility for any loss of Active Materials in defective Product will be captured and calculated in the Active Materials Yield under Section 2.2.

Appears in 1 contract

Samples: Product Agreement (Horizon Pharma, Inc.)

Time is Money Join Law Insider Premium to draft better contracts faster.